European Journal of Biomedical and Pharmaceutical Sciences

EFFECT OF ORAL IRON SUPPLEMENT IN POST MI PATIENTS DISCHARGED WITH MILD TO MODERATE PERSISTENT HOSPITAL ACQUIRED ANEMIA.

Rekha Sharma*, Rajnikant Srivastava, Kuldeep laller, Santprakash Kataria

ABSTRACT

Objectives: Evaluation of the outcomes of iron supplement in the patients hospital acquired anemia (HAA) in Acute myocardial infarction patients who survived their initial hospitalization at discharge. Material and methods: Prospective, randomized, comparative, open label, parallel study done on 40 patients who were divided into two groups of 20 patients each and were randomized to receive treatment either with oral iron therapy 100mg BD (Group 1) for 6 months and in Group 2 standard treatment of Post MI was given. Calculating Physical component score did efficacy assessment and mental component score using SF12 form. Observing for the side effects due to iron therapy also did safety assessment. Results: There was statistically significant increase in Hgb concentration at 1 month onwards after taking iron therapy and it subsequently kept on increasing till 6 months. Also the physical component score and mental component score was significantly increased at 3 and 6 months p<.005 Conclusion: Iron therapy significantly improved Hgb concentration and SF12. Physical component score and mental component score were also significantly increased.

Keywords: Hospital Acquired anemia, Short form 12, Hemoglobin, oral iron.